Standard Biotools Inc. SEC filings LAB

Standard Biotools Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 30, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Standard Biotools Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
425 Filing Nov 3, 2026 —
8-K Current report
Regulation FD disclosure
Nov 3, 2026 Nov 3, 2026
424B3 Prospectus Oct 30, 2026 —
EFFECT Filing Oct 21, 2026 —
424B3 Prospectus Oct 21, 2026 —
S-4/A Filing Oct 21, 2026 —
S-4/A Filing Oct 9, 2026 —
425 Filing Oct 5, 2026 —
8-K Current report
Regulation FD disclosure
Oct 5, 2026 Oct 5, 2026
425 Filing Sep 30, 2026 —
8-K Current report
Material agreement, Agreement ended, Regulation FD disclosure
Sep 30, 2026 Sep 30, 2026
S-4/A Filing Sep 9, 2026 —
S-8 Employee stock plan registration Aug 5, 2026 —
S-8 Employee stock plan registration Aug 5, 2026 —
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 5, 2026 Aug 5, 2026
425 Filing Jul 29, 2026 —
8-K/A Amended current report Jul 29, 2026 Jul 28, 2026
425 Filing Jul 28, 2026 —
425 Filing Jul 28, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 28, 2026 Jul 24, 2026
8-K Current report
Listing notice
Jul 24, 2026 Jul 22, 2026
425 Filing Jul 20, 2026 —
S-4 Registration for a merger or exchange Jul 20, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 18, 2026 Jun 17, 2026
425 Filing Jun 8, 2026 —
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change, Regulation FD disclosure
Jun 8, 2026 Jun 6, 2026
8-K Current report
Other events
Jun 5, 2026 Jun 5, 2026
8-K Current report
Officer or director change
Jun 3, 2026 May 29, 2026
SD Specialized disclosure (conflict minerals) May 29, 2026 —
8-K Current report
Officer or director change
May 28, 2026 May 21, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 27, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Jun 17, 2026
8-K Current report
Listing notice
Apr 24, 2026 Sep 13, 2025
10-K Annual report Mar 16, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Feb 24, 2026 Feb 24, 2026
8-K/A Amended current report Feb 5, 2026 Jan 30, 2026
8-K Current report
Acquisition or sale of assets, Results of operations, Regulation FD disclosure
Jan 30, 2026 Jan 30, 2026
8-K Current report
Results of operations
Jan 8, 2026 Jan 8, 2026
10-Q Quarterly report Nov 4, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 4, 2025 Nov 4, 2025
8-K Current report
Exit or restructuring costs
Sep 17, 2025 Sep 13, 2025
8-K Current report
Exit or restructuring costs
Sep 3, 2025 Aug 28, 2025
S-8 Employee stock plan registration Aug 15, 2025 —
10-Q Quarterly report Aug 15, 2025 Jun 30, 2025
NT 10-Q Filing Aug 12, 2025 Aug 11, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2025 Aug 11, 2025
8-K Current report
Officer or director change
Aug 1, 2025 Aug 1, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Jun 23, 2025 Jun 22, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 20, 2025 Jun 18, 2025
SD Specialized disclosure (conflict minerals) Jun 2, 2025 —
10-Q Quarterly report May 6, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 6, 2025 May 6, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 30, 2025 —
DEF 14A Proxy statement Apr 30, 2025 Jun 18, 2025
10-K Annual report Mar 11, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Feb 26, 2025 Feb 26, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
8-K Current report
Officer or director change
Jan 10, 2025 Jan 3, 2025
8-K Current report Dec 20, 2024 Dec 19, 2024
8-K Current report
Officer or director change
Nov 7, 2024 Nov 6, 2024
10-Q Quarterly report Nov 6, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Oct 30, 2024 Oct 30, 2024
8-K Current report
Regulation FD disclosure
Sep 5, 2024 Sep 5, 2024
8-K Current report
Officer or director change
Aug 30, 2024 Aug 27, 2024
S-8 Employee stock plan registration Aug 6, 2024 —
10-Q Quarterly report Aug 6, 2024 Jun 30, 2024
8-K Current report
Officer or director change
Jul 31, 2024 Jul 26, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jul 31, 2024 Jul 31, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jul 1, 2024 Jun 27, 2024
EFFECT Filing Jun 27, 2024 —
CORRESP Letter to the SEC Jun 25, 2024 —
UPLOAD Letter from the SEC Jun 25, 2024 —
S-3 Shelf registration Jun 20, 2024 —
DEFA14A Additional proxy material Jun 3, 2024 —
8-K Current report
Other events
Jun 3, 2024 May 31, 2024
SD Specialized disclosure (conflict minerals) May 29, 2024 —
ARS Annual report to shareholders May 21, 2024 Dec 31, 2023
DEFC14A Filing May 21, 2024 —
PRER14A Filing May 20, 2024 —
UPLOAD Letter from the SEC May 17, 2024 —
PREC14A Filing May 10, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Acquisition or sale of assets, Regulation FD disclosure
May 8, 2024 May 8, 2024
10-K/A Amended annual report Apr 26, 2024 Dec 31, 2023
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Apr 25, 2024 Apr 19, 2024
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
Mar 18, 2024 Mar 18, 2024
10-K Annual report Mar 1, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 28, 2024 Feb 28, 2024
EFFECT Filing Feb 7, 2024 —
EFFECT Filing Feb 7, 2024 —
CORRESP Letter to the SEC Feb 5, 2024 —
CORRESP Letter to the SEC Feb 5, 2024 —
S-3/A Filing Feb 2, 2024 —
UPLOAD Letter from the SEC Feb 1, 2024 —
UPLOAD Letter from the SEC Feb 1, 2024 —
S-3 Shelf registration Jan 19, 2024 —
S-3 Shelf registration Jan 19, 2024 —
S-8 Employee stock plan registration Jan 19, 2024 —
S-8 Employee stock plan registration Jan 19, 2024 —
8-K/A Amended current report Jan 19, 2024 Jan 4, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Jan 8, 2024 Jan 8, 2024
8-K Current report
Acquisition or sale of assets, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Jan 5, 2024 Jan 4, 2024
425 Filing Dec 29, 2023 —
8-K Current report
Other events
Dec 29, 2023 Dec 29, 2023
425 Filing Dec 26, 2023 —
8-K Current report
Other events
Dec 26, 2023 Dec 22, 2023
424B3 Prospectus Dec 22, 2023 —
425 Filing Dec 19, 2023 —
8-K Current report
Regulation FD disclosure, Other events
Dec 19, 2023 Dec 19, 2023
425 Filing Dec 4, 2023 —
8-K Current report
Other events
Dec 4, 2023 Dec 4, 2023
EFFECT Filing Dec 1, 2023 —
424B3 Prospectus Dec 1, 2023 —
CORRESP Letter to the SEC Dec 1, 2023 —
S-4/A Filing Dec 1, 2023 —
425 Filing Nov 29, 2023 —
8-K Current report
Regulation FD disclosure
Nov 29, 2023 Nov 28, 2023
UPLOAD Letter from the SEC Nov 27, 2023 —
425 Filing Nov 21, 2023 —
8-K Current report
Other events
Nov 21, 2023 Nov 20, 2023
S-4 Registration for a merger or exchange Nov 14, 2023 —
CORRESP Letter to the SEC Nov 13, 2023 —
425 Filing Nov 8, 2023 —
10-Q Quarterly report Nov 7, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2023 Nov 7, 2023
425 Filing Oct 4, 2023 —
425 Filing Oct 4, 2023 —
425 Filing Oct 4, 2023 —
425 Filing Oct 4, 2023 —
425 Filing Oct 4, 2023 —
425 Filing Oct 4, 2023 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Oct 4, 2023 Oct 4, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 8, 2023 Aug 8, 2023
8-K Current report
Officer or director change
Jul 28, 2023 Jul 24, 2023
S-8 Employee stock plan registration Jun 20, 2023 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 16, 2023 Jun 14, 2023
SD Specialized disclosure (conflict minerals) May 26, 2023 —
8-K Current report
Officer or director change
May 15, 2023 May 10, 2023
10-Q Quarterly report May 9, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 9, 2023 May 9, 2023
8-K Current report
Officer or director change
May 3, 2023 Apr 28, 2023
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 14, 2023
8-K Current report
Officer or director change
Mar 16, 2023 Mar 15, 2023
10-K Annual report Mar 14, 2023 Dec 31, 2022
8-K Current report
Other events
Mar 13, 2023 Mar 13, 2023
8-K Current report
Results of operations
Feb 14, 2023 Feb 14, 2023
8-K Current report
Results of operations
Jan 9, 2023 Jan 9, 2023
8-K Current report
Other events
Nov 28, 2022 Nov 28, 2022
10-Q Quarterly report Nov 9, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
10-Q Quarterly report Aug 9, 2022 Jun 30, 2022
8-K Current report
Results of operations, Exit or restructuring costs
Aug 8, 2022 Aug 8, 2022
8-K Current report
Officer or director change
Aug 3, 2022 Jul 29, 2022
8-K Current report
Officer or director change
Jul 7, 2022 Jun 30, 2022
8-K Current report
Officer or director change
Jun 27, 2022 Jun 22, 2022
8-K Current report
Shareholder vote results
Jun 16, 2022 Jun 15, 2022
SD Specialized disclosure (conflict minerals) May 31, 2022 —
424B3 Prospectus May 27, 2022 —
EFFECT Filing May 26, 2022 —
CORRESP Letter to the SEC May 25, 2022 —
UPLOAD Letter from the SEC May 24, 2022 —
S-3 Shelf registration May 17, 2022 —
10-Q Quarterly report May 9, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 29, 2022 —
DEF 14A Proxy statement Apr 29, 2022 Jun 15, 2022
8-K Current report
Material agreement, Agreement ended, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
Apr 5, 2022 Apr 1, 2022
S-8 Employee stock plan registration Apr 1, 2022 —
DEFR14A Filing Mar 29, 2022 —
8-K Current report
Material agreement, Officer or director change
Mar 29, 2022 Mar 28, 2022
DEFR14A Filing Mar 28, 2022 —
8-K Current report
Material agreement, Shareholder vote results, Other events
Mar 28, 2022 Mar 25, 2022
DEFA14A Additional proxy material Mar 22, 2022 —
DEFA14A Additional proxy material Mar 21, 2022 —
DEFA14A Additional proxy material Mar 18, 2022 —
8-K Current report
Officer or director change
Mar 16, 2022 Mar 10, 2022
DEFA14A Additional proxy material Mar 14, 2022 —
10-K Annual report Mar 8, 2022 Dec 31, 2021
DEFA14A Additional proxy material Mar 4, 2022 —
DEF 14A Proxy statement Feb 24, 2022 Mar 25, 2022
DEFA14A Additional proxy material Feb 18, 2022 —
8-K Current report
Results of operations
Feb 18, 2022 Feb 17, 2022
DEFA14A Additional proxy material Feb 14, 2022 —
DEFA14A Additional proxy material Feb 14, 2022 —
PRE 14A Preliminary proxy statement Feb 14, 2022 Feb 11, 2022
DEFA14A Additional proxy material Feb 11, 2022 —
8-K/A Amended current report Feb 11, 2022 Jan 23, 2022
DEFA14A Additional proxy material Jan 24, 2022 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Jan 24, 2022 Jan 23, 2022
DEFA14A Additional proxy material Jan 24, 2022 —
DEFA14A Additional proxy material Jan 24, 2022 —
DEFA14A Additional proxy material Jan 24, 2022 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LAB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Accelerated filer
SEC CIK
1162194
Former names
FLUIDIGM CORP (until Apr 1, 2022)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.